0
Article |

INTRADERMAL TESTS IN RELATION TO ARSPHENAMINE DERMATITIS:  A STUDY BASED ON TWO HUNDRED AND FIFTY-SIX CLINICAL CASES

A. BENSON CANNON, M.D.; MARIE B. KARELITZ, M.D.
Arch Derm Syphilol. 1934;29(4):485-520. doi:10.1001/archderm.1934.01460100003001.
Text Size: A A A
Published online

Introduction

Method and Technic

Time and Number of Tests

Observation after Tests

Types of Reactions

Immediate, Early and Delayed Reactions

"Positive" Reactions

Reactions to First and Later Tests Compared

Tests in Patients With and Without Arsphenamine Therapy

Intradermal Tests in Tolerant as Compared with Intolerant Patients

Tests in Patients without Arsphenamine Therapy

Intradermal Test as an Aid in Diagnosis and Prognosis of Complications from Arsphenamine Therapy

The Test in Diagnosis: Specificity

Reactions to Different Arsphenamines

Differences in Reaction to Arsphenamines and to Other Arsenical Preparations

Epidermal Reactions as Compared with Other Types

The Test in Prognosis

Syphilitic Patients not yet Treated with the Arsphenamines

Syphilitic Patients Previously Tolerant of the Arsphenamines

Sensitization and Desensitization

The Test as a Sensitizer

Reaction of Patients to Subsequent Intravenous Injections

Reaction of Patients to Repeated Intradermal Tests

Arsphenamine Dermatitis as a Phenomenon of Sensitization

Dermatitis after Few Injections and Small Doses

Polyvalent Sensitization

Rôle

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs